Device Trial Radar · NCT06186765
F15 Recharge Free Axonics SNM System Clinical Study
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
144
Actual
Start
Dec 8, 2023
Primary completion
Dec 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- Axonics, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 2, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Multicenter, prospective, non randomized, single arm evaluation of patients with overactive bladder (OAB) and/or fecal incontinence (FI) employing the Axonics recharge free SNM System.
Conditions
- Urinary Urge Incontinence (UUI)
- Urinary Frequency (UF)
- Fecal Incontinence (FI)
Interventions
Axonics SNM System (Model 4101)Device
Safety and performance/effectiveness assessment of the recharge free Axonics SNM System (Model 4101 in participants with overactive bladder (OAB) or fecal incontinence (FI).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Performance/Effectiveness - Improvement in Quality of Life scoring (OAB)Time frame: 3 months
- Performance/Effectiveness - Improvement in Fecal Incontinence SurveyTime frame: 3 months
- Adverse event reporting (Safety)Time frame: 3 months
Locations
16 sites in 3 countries. Site status is shown where the registry gives one.
Hartford Healthcare
Waterford, Connecticut
Florida Gulf Clinical Research
Bradenton, Florida
East Coast Institute of Research
Jacksonville, Florida
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.